TET1 anticorps (AA 1700-1800) (FITC)

N° du produit ABIN7159635

Détail du produit anti-TET1 anticorps (FITC)

Antigène: TET1 (Tet Methylcytosine Dioxygenase 1 (TET1))

Épitope: AA 1700-1800

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TET1 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Methylcytosine dioxygenase TET1 protein (1700-1800AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur TET1

Antigène: TET1 (Tet Methylcytosine Dioxygenase 1 (TET1))

Autre désignation: TET1 (TET1 Produits)

Synonymes: anticorps CXXC6, anticorps LCX, anticorps bA119F7.1, anticorps 2510010B09Rik, anticorps AA517754, anticorps BB001228, anticorps Cxxc6, anticorps D10Ertd17e, anticorps mKIAA1676, anticorps tet methylcytosine dioxygenase 1, anticorps solute carrier family 25 member 16, anticorps TET1, anticorps Tet1, anticorps SLC25A16

Sujet:

Background: Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, plays a more general role in chromatin regulation. Preferentially binds to CpG-rich sequences at promoters of both transcriptionally active and Polycomb-repressed genes. Involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT. Also involved in transcription repression of a subset of genes through recruitment of transcriptional repressors to promoters. Involved in the balance between pluripotency and lineage commitment of cells it plays a role in embryonic stem cells maintenance and inner cell mass cell specification. Plays an important role in the tumorigenicity of glioblastoma cells. TET1-mediated production of 5hmC acts as a recruitment signal for the CHTOP-methylosome complex to selective sites on the chromosome, where it methylates H4R3 and activates the transcription of genes involved in glioblastomagenesis (PubMed:25284789).

Aliases: bA119F7.1 antibody, CXXC 6 antibody, CXXC finger 6 antibody, CXXC type zinc finger protein 6 antibody, CXXC zinc finger 6 antibody, CXXC-type zinc finger protein 6 antibody, CXXC6 antibody, KIAA1676 antibody, LCX antibody, Leukemia associated protein with a CXXC domain antibody, Leukemia-associated protein with a CXXC domain antibody, Methylcytosine dioxygenase TET1 antibody, Ten eleven translocation 1 antibody, Ten eleven translocation 1 gene protein antibody, Ten eleven translocation 1 gene protein homolog antibody, Ten-eleven translocation 1 gene protein antibody, Tet 1 antibody, Tet methylcytosine dioxygenase 1 antibody, Tet oncogene 1 antibody, TET1 antibody, TET1_HUMAN antibody

UniProt: Q8NFU7

Pathways: Stem Cell Maintenance, L'effet Warburg